Kangwei Xu

Beijing, 102629, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity.

Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity.

Journal: Vaccines
Published: April 28, 2026

KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E.

KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E.

Journal: Frontiers in immunology
Published: April 07, 2026

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice.

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice.

Journal: Viruses
Published: November 20, 2025

A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine.

A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine.

Journal: Frontiers in immunology
Published: June 04, 2025

Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model.

Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model.

Journal: Vaccines
Published: June 19, 2024

The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice.

The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice.

Journal: Vaccines
Published: November 28, 2023

The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC-MS.

The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC-MS.

Journal: Vaccines
Published: April 14, 2023

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.

Journal: Vaccine
Published: July 27, 2021

Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.

Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.

Journal: Emerging microbes & infections
Published: July 19, 2021

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques.

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques.

Journal: Molecular therapy. Methods & clinical development
Published: January 06, 2021

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged ≥3 years.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged ≥3 years.

Journal: Vaccine
Published: April 28, 2020

Development of an inactivated vaccine candidate for SARS-CoV-2.

Development of an inactivated vaccine candidate for SARS-CoV-2.

Journal: Science (New York, N.Y.)
Published: April 10, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026